Kymera Therapeutics (KYMR) Asset Utilization Ratio (2020 - 2026)

Kymera Therapeutics (KYMR) has 7 years of Asset Utilization Ratio data on file, last reported at 0.03 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 51.41% year-over-year to 0.03 in Q1 2026; TTM through Mar 2026 was 0.03, a 51.41% decrease from a year earlier, with the FY2025 full-year figure at 0.03, down 52.43% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.03, up from 0.03 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for KYMR reached as high as 0.14 in Q4 2023 and fell as low as 0.03 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.08 across 5 years, with a median of 0.08 in 2022.
• Across the five-year window, Asset Utilization Ratio jumped 84.72% in 2023 and tumbled 66.43% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.08 in 2022, then soared by 84.72% to 0.14 in 2023, then tumbled by 66.43% to 0.05 in 2024, then tumbled by 41.06% to 0.03 in 2025, then advanced by 9.46% to 0.03 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.03 in Q1 2026, 0.03 in Q4 2025, and 0.04 in Q3 2025.